Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
Amino M, Yoshioka K, Opthof T, Morita S, Uemura S, Tamura K, Fukushima T, Higami S, Otsuka H, Akieda K, Shima M, Fujibayashi D, Hashida T, Inokuchi S, Kodama I, Tanabe T.
Amino M, et al. Among authors: shima m.
J Cardiovasc Pharmacol. 2010 Apr;55(4):391-8. doi: 10.1097/FJC.0b013e3181d3dcc7.
J Cardiovasc Pharmacol. 2010.
PMID: 20147846
Clinical Trial.